| Year |
Citation |
Score |
| 2022 |
Kim IT, Farb C, Hou M, Prasad S, Talley E, Cook S, Campese VD. General and Specific Aversive Modulation of Active Avoidance Require Central Amygdala. Frontiers in Behavioral Neuroscience. 16: 879168. PMID 35795380 DOI: 10.3389/fnbeh.2022.879168 |
0.816 |
|
| 2021 |
Campese VD, Brannigan LA, LeDoux JE. Conditional Control of Instrumental Avoidance by Context Following Extinction. Frontiers in Behavioral Neuroscience. 15: 730113. PMID 34650411 DOI: 10.3389/fnbeh.2021.730113 |
0.644 |
|
| 2021 |
Campese VD. The Lesser Evil: Pavlovian-Instrumental Transfer & Aversive Motivation. Behavioural Brain Research. 113431. PMID 34175357 DOI: 10.1016/j.bbr.2021.113431 |
0.481 |
|
| 2019 |
Campese VD, Kim IT, Hou M, Gupta S, Draus C, Kurpas B, Burke K, LeDoux JE. Chemogenetic inhibition reveals that processing relative but not absolute threat requires basal amygdala. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 31492771 DOI: 10.1523/JNEUROSCI.2530-18.2019 |
0.81 |
|
| 2017 |
Campese VD, Soroeta JM, Vazey EM, Aston-Jones G, LeDoux JE, Sears RM. Noradrenergic Regulation of Central Amygdala in Aversive Pavlovian-to-Instrumental Transfer. Eneuro. 4. PMID 29071299 DOI: 10.1523/ENEURO.0224-17.2017 |
0.78 |
|
| 2017 |
Campese VD, Kim IT, Rojas G, LeDoux JE. Pavlovian Extinction and Recovery Effects in Aversive Pavlovian to Instrumental Transfer. Frontiers in Behavioral Neuroscience. 11: 179. PMID 28993726 DOI: 10.3389/fnbeh.2017.00179 |
0.806 |
|
| 2017 |
Díaz-Mataix L, Piper WT, Schiff HC, Roberts CH, Campese VD, Sears RM, LeDoux JE. Characterization of the amplificatory effect of norepinephrine in the acquisition of Pavlovian threat associations. Learning & Memory (Cold Spring Harbor, N.Y.). 24: 432-439. PMID 28814469 DOI: 10.1101/Lm.044412.116 |
0.796 |
|
| 2016 |
LeDoux JE, Moscarello J, Sears R, Campese V. The birth, death and resurrection of avoidance: a reconceptualization of a troubled paradigm. Molecular Psychiatry. PMID 27752080 DOI: 10.1038/Mp.2016.166 |
0.805 |
|
| 2015 |
Campese VD, Sears RM, Moscarello JM, Diaz-Mataix L, Cain CK, LeDoux JE. The Neural Foundations of Reaction and Action in Aversive Motivation. Current Topics in Behavioral Neurosciences. PMID 26643998 DOI: 10.1007/7854_2015_401 |
0.791 |
|
| 2015 |
Campese VD, Gonzaga R, Moscarello JM, LeDoux JE. Modulation of instrumental responding by a conditioned threat stimulus requires lateral and central amygdala. Frontiers in Behavioral Neuroscience. 9: 293. PMID 26578921 DOI: 10.3389/Fnbeh.2015.00293 |
0.809 |
|
| 2015 |
Dunsmoor JE, Campese VD, Ceceli AO, LeDoux JE, Phelps EA. Novelty-Facilitated Extinction: Providing a Novel Outcome in Place of an Expected Threat Diminishes Recovery of Defensive Responses. Biological Psychiatry. 78: 203-9. PMID 25636175 DOI: 10.1016/j.biopsych.2014.12.008 |
0.677 |
|
| 2014 |
Campese VD, Kim J, Lázaro-Muñoz G, Pena L, LeDoux JE, Cain CK. Lesions of lateral or central amygdala abolish aversive Pavlovian-to-instrumental transfer in rats. Frontiers in Behavioral Neuroscience. 8: 161. PMID 24847229 DOI: 10.3389/Fnbeh.2014.00161 |
0.829 |
|
| 2014 |
Campese VD, Delamater AR. Dorsal hippocampus inactivation impairs spontaneous recovery of Pavlovian magazine approach responding in rats. Behavioural Brain Research. 269: 37-43. PMID 24742862 DOI: 10.1016/J.Bbr.2014.04.014 |
0.753 |
|
| 2013 |
Campese V, McCue M, Lázaro-Muñoz G, Ledoux JE, Cain CK. Development of an aversive Pavlovian-to-instrumental transfer task in rat. Frontiers in Behavioral Neuroscience. 7: 176. PMID 24324417 DOI: 10.3389/Fnbeh.2013.00176 |
0.835 |
|
| 2013 |
Campese V, Delamater AR. ABA and ABC renewal of conditioned magazine approach are not impaired by dorsal hippocampus inactivation or lesions. Behavioural Brain Research. 248: 62-73. PMID 23583520 DOI: 10.1016/J.Bbr.2013.03.044 |
0.751 |
|
| 2012 |
Scarlet J, Delamater AR, Campese V, Fein M, Wheeler DS. Differential involvement of the basolateral amygdala and orbitofrontal cortex in the formation of sensory-specific associations in conditioned flavor preference and magazine approach paradigms. The European Journal of Neuroscience. 35: 1799-809. PMID 22672133 DOI: 10.1111/J.1460-9568.2012.08113.X |
0.737 |
|
| 2009 |
Scarlet J, Campese V, Delamater AR. Sensory-specific associations in flavor-preference reversal learning. Learning & Behavior. 37: 179-87. PMID 19380895 DOI: 10.3758/Lb.37.2.179 |
0.722 |
|
| 2009 |
Delamater AR, Campese V, Westbrook RF. Renewal and spontaneous recovery, but not latent inhibition, are mediated by gamma-aminobutyric acid in appetitive conditioning. Journal of Experimental Psychology. Animal Behavior Processes. 35: 224-37. PMID 19364231 DOI: 10.1037/A0013293 |
0.711 |
|
| 2006 |
Delamater AR, Campese V, LoLordo VM, Sclafani A. Unconditioned stimulus devaluation effects in nutrient-conditioned flavor preferences. Journal of Experimental Psychology. Animal Behavior Processes. 32: 295-306. PMID 16834496 DOI: 10.1037/0097-7403.32.3.295 |
0.816 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 1994 |
Bigazzi R, Kogosov E, Campese VM. Altered norepinephrine turnover in the brain of rats with chronic renal failure. Journal of the American Society of Nephrology : Jasn. 4: 1901-7. PMID 7919142 |
0.174 |
|
| 1995 |
Campese VM, Kogosov E. Renal afferent denervation prevents hypertension in rats with chronic renal failure. Hypertension. 25: 878-82. PMID 7721447 |
0.145 |
|
| 2000 |
Campese VM, Ye S, Truong RH, Gamburd M. Losartan reduces sympathetic nerve outflow from the brain of rats with chronic renal failure. Journal of the Renin-Angiotensin-Aldosterone System : Jraas. 1: 202-8. PMID 11967814 DOI: 10.3317/jraas.2000.026 |
0.139 |
|
| 2002 |
Campese VM, Mozayeni P, Ye S, Gumbard M. High salt intake inhibits nitric oxide synthase expression and aggravates hypertension in rats with chronic renal failure. Journal of Nephrology. 15: 407-13. PMID 12243372 |
0.137 |
|
| 1985 |
Iseki K, Massry SG, Campese VM. Evidence for a role of PTH in the reduced pressor response to norepinephrine in chronic renal failure Kidney International. 28: 11-15. PMID 4046321 |
0.136 |
|
| 1987 |
Bhaskaran D, Massry SG, Campese VM. Effect of hypophosphatemia on brain catecholamines content in the rat Mineral and Electrolyte Metabolism. 13: 469-472. PMID 3696100 |
0.131 |
|
| 1997 |
Ye S, Nosrati S, Campese VM. Nitric oxide (NO) modulates the neurogenic control of blood pressure in rats with chronic renal failure (CRF). The Journal of Clinical Investigation. 99: 540-8. PMID 9022090 DOI: 10.1172/JCI119191 |
0.125 |
|
| 1986 |
El-Belbessi S, Braulbar N, Anderson K, Campese VM, Massry SG. Effect of chronic renal failure on heart: Role of secondary hyperparathyroidism American Journal of Nephrology. 6: 369-375. PMID 3826135 DOI: 10.1159/000167193 |
0.123 |
|
| 1991 |
Brenner BM, Maschio G, Campese VM. Foreword American Journal of Kidney Diseases. 17: 1. |
0.12 |
|
| 1988 |
Fadda GZ, Massry SG, El-Refai M, Campese VM. Alpha1 adrenergic receptors in mesenteric arteries of rats with chronic renal failure Kidney International. 34: 463-466. PMID 2848971 |
0.12 |
|
| 1994 |
Bigazzi R, Kogosov E, Campese VM. Altered norepinephrine turnover in the brown fat of rats with chronic renal failure Journal of the American Society of Nephrology. 4: 1896-1900. PMID 7919141 |
0.12 |
|
| 1997 |
Ye S, Ozgur B, Campese VM. Renal afferent impulses, the posterior hypothalamus, and hypertension in rats with chronic renal failure. Kidney International. 51: 722-7. PMID 9067904 |
0.119 |
|
| 2023 |
Campese VD, Laurent V. Editorial: Pavlovian-instrumental transfer: Neurobehavioral and clinical findings. Frontiers in Behavioral Neuroscience. 17: 1151180. PMID 36891322 DOI: 10.3389/fnbeh.2023.1151180 |
0.108 |
|
| 2000 |
Ye S, Mozayeni P, Gamburd M, Zhong H, Campese VM. Interleukin-1beta and neurogenic control of blood pressure in normal rats and rats with chronic renal failure. American Journal of Physiology. Heart and Circulatory Physiology. 279: H2786-96. PMID 11087233 |
0.1 |
|
| 2008 |
Park J, Campese VM, Middlekauff HR. Exercise pressor reflex in humans with end-stage renal disease. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 295: R1188-94. PMID 18685067 DOI: 10.1152/ajpregu.90473.2008 |
0.1 |
|
| 1999 |
Campese VM, Bianchi S, Bigazzi R. Association between hyperlipidemia and microalbuminuria in essential hypertension. Kidney International. Supplement. 71: S10-3. PMID 10412727 |
0.098 |
|
| 1985 |
Collins J, Massry SG, Campese VM. Parathyroid hormone and the altered vascular response to norepinephrine in uremia American Journal of Nephrology. 5: 110-113. PMID 3993699 |
0.096 |
|
| 2004 |
Campese VM, Ye S, Zhong H, Yanamadala V, Ye Z, Chiu J. Reactive oxygen species stimulate central and peripheral sympathetic nervous system activity. American Journal of Physiology. Heart and Circulatory Physiology. 287: H695-703. PMID 15277201 DOI: 10.1152/ajpheart.00619.2003 |
0.095 |
|
| 2009 |
Ku E, Campese VM. Role of aldosterone in the progression of chronic kidney disease and potential use of aldosterone blockade in children. Pediatric Nephrology (Berlin, Germany). 24: 2301-7. PMID 19347366 DOI: 10.1007/s00467-009-1176-z |
0.093 |
|
| 1989 |
Smogorzewski M, Campese VM, Massry SG. Abnormal norepinephrine uptake and release in brain synaptosomes in chronic renal failure Kidney International. 36: 458-465. PMID 2556607 |
0.093 |
|
| 1986 |
Iseki K, Massry SG, Campese VM. Effects of hypercalcemia and parathyroid hormone on blood pressure in normal and renal-failure rats American Journal of Physiology - Renal Fluid and Electrolyte Physiology. 250: 19/5. PMID 3706544 |
0.092 |
|
| 1985 |
Saglikes Y, Massry SG, Iseki K, Nadler JL, Campese VM. Effect of PTH on blood pressure and response to vasoconstrictor agonists The American Journal of Physiology. 248: F674-681. PMID 3838858 |
0.09 |
|
| 1985 |
Saglikes Y, Massry SG, Iseki K, Brautbar N, Barndt R, Brunton LL, Buxton IL, Vlachakis N, Campese VM. Effect of phosphate depletion on blood pressure and vascular reactivity to norepinephrine and angiotensin II in the rat The American Journal of Physiology. 248: F93-99. PMID 3881979 DOI: 10.1152/AJPRENAL.1985.248.1.F93 |
0.09 |
|
| 1992 |
Liu CL, Bigazzi R, Ballard J, Campese VM. Effect of hypercalcemia on renal sympathetic nervous system activity American Journal of Nephrology. 12: 86-93. PMID 1415371 |
0.089 |
|
| 2009 |
Ku E, Nobakht N, Campese VM. Lixivaptan: a novel vasopressin receptor antagonist. Expert Opinion On Investigational Drugs. 18: 657-62. PMID 19379124 DOI: 10.1517/13543780902889760 |
0.088 |
|
| 1997 |
Campese VM. Neurogenic factors and hypertension in chronic renal failure. Journal of Nephrology. 10: 184-7. PMID 9377724 |
0.085 |
|
| 2002 |
Ferrario CM, Smith RD, Brosnihan B, Chappell MC, Campese VM, Vesterqvist O, Liao WC, Ruddy MC, Grim CE. Effects of omapatrilat on the renin-angiotensin system in salt-sensitive hypertension. American Journal of Hypertension. 15: 557-64. PMID 12074359 DOI: 10.1016/S0895-7061(02)02268-9 |
0.084 |
|
| 1995 |
Campese VM, Kogosov E, Koss M. Renal afferent denervation prevents the progression of renal disease in the renal ablation model of chronic renal failure in the rat. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 26: 861-5. PMID 7485145 DOI: 10.1016/0272-6386(95)90456-5 |
0.08 |
|
| 2002 |
Ye S, Zhong H, Duong VN, Campese VM. Losartan reduces central and peripheral sympathetic nerve activity in a rat model of neurogenic hypertension. Hypertension. 39: 1101-6. PMID 12052849 DOI: 10.1161/01.HYP.0000018590.26853.C7 |
0.078 |
|
| 2005 |
Campese VM, Nadim MK, Epstein M. Are 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors renoprotective? Journal of the American Society of Nephrology : Jasn. 16: S11-7. PMID 15938026 DOI: 10.1681/ASN.2004110958 |
0.077 |
|
| 2003 |
Bianchi S, Bigazzi R, Caiazza A, Campese VM. A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 41: 565-70. PMID 12612979 DOI: 10.1053/ajkd.2003.50140 |
0.077 |
|
| 2012 |
Park J, Middlekauff HR, Campese VM. Abnormal sympathetic reactivity to the cold pressor test in overweight humans. American Journal of Hypertension. 25: 1236-41. PMID 22895452 DOI: 10.1038/ajh.2012.115 |
0.076 |
|
| 1996 |
Campese VM, Tawadrous M, Bigazzi R, Bianchi S, Mann AS, Oparil S, Raij L. Salt intake and plasma atrial natriuretic peptide and nitric oxide in hypertension. Hypertension. 28: 335-40. PMID 8794813 |
0.076 |
|
| 1992 |
Buchanan TA, Sipos GF, Madrilejo N, Liu C, Campese VM. Hypertension without peripheral insulin resistance in spontaneously hypertensive rats American Journal of Physiology - Endocrinology and Metabolism. 262: E14-E19. PMID 1733245 |
0.075 |
|
| 2006 |
Ye S, Zhong H, Yanamadala S, Campese VM. Oxidative stress mediates the stimulation of sympathetic nerve activity in the phenol renal injury model of hypertension. Hypertension. 48: 309-15. PMID 16785328 DOI: 10.1161/01.HYP.0000231307.69761.2e |
0.074 |
|
| 2002 |
Campese VM, Krol E. Neurogenic factors in renal hypertension. Current Hypertension Reports. 4: 256-60. PMID 12003710 DOI: 10.1007/s11906-002-0016-3 |
0.072 |
|
| 2009 |
Bai Y, Jabbari B, Ye S, Campese VM, Vaziri ND. Regional expression of NAD(P)H oxidase and superoxide dismutase in the brain of rats with neurogenic hypertension. American Journal of Nephrology. 29: 483-92. PMID 19047792 DOI: 10.1159/000178817 |
0.072 |
|
| 2004 |
Epstein M, Campese VM. Evolving role of calcium antagonists in the management of hypertension. The Medical Clinics of North America. 88: 149-65. PMID 14871057 DOI: 10.1016/S0025-7125(03)00123-8 |
0.071 |
|
| 2007 |
Campese VM, Sindhu RK, Ye S, Bai Y, Vaziri ND, Jabbari B. Regional expression of NO synthase, NAD(P)H oxidase and superoxide dismutase in the rat brain. Brain Research. 1134: 27-32. PMID 17196179 DOI: 10.1016/j.brainres.2006.11.067 |
0.071 |
|
| 2011 |
Campese VM, Ku E, Park J. Sympathetic renal innervation and resistant hypertension. International Journal of Hypertension. 2011: 814354. PMID 21331158 DOI: 10.4061/2011/814354 |
0.071 |
|
| 2005 |
Campese VM, Hadaya B, Chiu J. HMG-CoA reductase inhibitors and the kidney. Current Hypertension Reports. 7: 337-42. PMID 16157074 |
0.07 |
|
| 2013 |
Schlaich MP, Schmieder RE, Bakris G, Blankestijn PJ, Böhm M, Campese VM, Francis DP, Grassi G, Hering D, Katholi R, Kjeldsen S, Krum H, Mahfoud F, Mancia G, Messerli FH, et al. International expert consensus statement: Percutaneous transluminal renal denervation for the treatment of resistant hypertension. Journal of the American College of Cardiology. 62: 2031-45. PMID 24021387 DOI: 10.1016/j.jacc.2013.08.1616 |
0.07 |
|
| 2007 |
Campese VM, Park J. HMG-CoA reductase inhibitors and the kidney. Kidney International. 71: 1215-22. PMID 17495867 DOI: 10.1038/sj.ki.5002174 |
0.07 |
|
| 1994 |
Campese VM. Neurogenic factors in hypertension: therapeutic implications. Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societã Italiana Di Medicina Interna. 9: 39S-43S. PMID 7857755 |
0.068 |
|
| 2010 |
Lu Y, Ku E, Campese VM. Aldosterone in the pathogenesis of chronic kidney disease and proteinuria. Current Hypertension Reports. 12: 303-6. PMID 20596805 DOI: 10.1007/s11906-010-0116-4 |
0.067 |
|
| 1996 |
Gadallah MF, el-Shahawy MA, Campese VM, Todd JR, King JW. Disparate prognosis of thrombotic microangiopathy in HIV-infected patients with and without AIDS. American Journal of Nephrology. 16: 446-50. PMID 8886184 |
0.067 |
|
| 1992 |
Buchanan TA, Youn JH, Campese VM, Sipos GF. Enhanced glucose tolerance in spontaneously hypertensive rats: Pancreatic β-cell hyperfunction with normal insulin sensitivity Diabetes. 41: 872-878. PMID 1612202 |
0.067 |
|
| 2007 |
Bai Y, Ye S, Mortazavi R, Campese V, Vaziri ND. Effect of renal injury-induced neurogenic hypertension on NO synthase, caveolin-1, AKt, calmodulin and soluble guanylate cyclase expressions in the kidney. American Journal of Physiology. Renal Physiology. 292: F974-80. PMID 17122386 DOI: 10.1152/ajprenal.00157.2006 |
0.067 |
|
| 2014 |
Amarenco P, Callahan A, Campese VM, Goldstein LB, Hennerici MG, Messig M, Sillesen H, Welch KM, Wilson DJ, Zivin JA. Effect of high-dose atorvastatin on renal function in subjects with stroke or transient ischemic attack in the SPARCL trial. Stroke; a Journal of Cerebral Circulation. 45: 2974-82. PMID 25147328 DOI: 10.1161/STROKEAHA.114.005832 |
0.066 |
|
| 2006 |
Campese VM, Park J. The kidney and hypertension: over 70 years of research. Journal of Nephrology. 19: 691-8. PMID 17173239 |
0.066 |
|
| 1998 |
Ye S, Gamburd M, Mozayeni P, Koss M, Campese VM. A limited renal injury may cause a permanent form of neurogenic hypertension. American Journal of Hypertension. 11: 723-8. PMID 9657632 DOI: 10.1016/S0895-7061(98)00030-2 |
0.066 |
|
| 1991 |
Campese VM, Karubian F. Salt sensitivity in hypertension: Implications for the kidney Journal of the American Society of Nephrology. 2: S53-S61. PMID 1932644 |
0.065 |
|
| 2008 |
Park J, Campese VM, Nobakht N, Middlekauff HR. Differential distribution of muscle and skin sympathetic nerve activity in patients with end-stage renal disease. Journal of Applied Physiology (Bethesda, Md. : 1985). 105: 1873-6. PMID 18845779 DOI: 10.1152/japplphysiol.90849.2008 |
0.064 |
|
| 2000 |
Campese VM. The kidney and the neurogenic control of blood pressure in renal disease. Journal of Nephrology. 13: 221-4. PMID 10928299 DOI: 10.1097/00041552-199903000-00010 |
0.064 |
|
| 2005 |
Epstein M, Campese VM. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors on renal function. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 45: 2-14. PMID 15696439 DOI: 10.1053/j.ajkd.2004.08.040 |
0.064 |
|
| 2003 |
Yang LE, Leong PK, Ye S, Campese VM, McDonough AA. Responses of proximal tubule sodium transporters to acute injury-induced hypertension. American Journal of Physiology. Renal Physiology. 284: F313-22. PMID 12388425 DOI: 10.1152/ajprenal.00134.2002 |
0.063 |
|
| 2000 |
Campese VM. Neurogenic factors and hypertension in renal disease. Kidney International. Supplement. 75: S2-6. PMID 10828754 |
0.062 |
|
| 2007 |
Campese VM, Ye S. A vitamin-E-fortified diet reduces oxidative stress, sympathetic nerve activity, and hypertension in the phenol-renal injury model in rats. Journal of the American Society of Hypertension : Jash. 1: 242-50. PMID 20409856 DOI: 10.1016/j.jash.2007.04.003 |
0.061 |
|
| 1994 |
El-Shahawy MA, Gadallah MF, Campese VM. Tuberculosis of the spine (Pott's disease) in patients with end-stage renal disease American Journal of Nephrology. 14: 55-59. PMID 8017482 |
0.06 |
|
| 2002 |
Campese VM, Ye S, Zhong H. Downregulation of neuronal nitric oxide synthase and interleukin-1beta mediates angiotensin II-dependent stimulation of sympathetic nerve activity. Hypertension. 39: 519-24. PMID 11882601 DOI: 10.1161/hy0202.102815 |
0.06 |
|
| 1998 |
Bigazzi R, Bianchi S, Baldari D, Campese VM. Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension. Journal of Hypertension. 16: 1325-33. PMID 9746120 DOI: 10.1097/00004872-199816090-00014 |
0.059 |
|
| 2014 |
Campese VM. Dyslipidemia and progression of kidney disease: role of lipid-lowering drugs. Clinical and Experimental Nephrology. 18: 291-5. PMID 24535025 DOI: 10.1007/s10157-014-0934-9 |
0.059 |
|
| 1993 |
Campese VM, Karubian F, Chervu I, Parise M, Sarkies N, Bigazzi R. Pressor reactivity to norepinephrine and angiotensin in salt-sensitive hypertensive patients Hypertension. 21: 301-307. PMID 8478039 |
0.058 |
|
| 1993 |
Campese VM. Sympathetic nerve activity and hypertension in rats with chronic renal failure Blood Purification. 11: 30-31. |
0.058 |
|
| 2006 |
Bianchi S, Bigazzi R, Campese VM. Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease. Kidney International. 70: 2116-23. PMID 17035949 DOI: 10.1038/sj.ki.5001854 |
0.057 |
|
| 2005 |
Campese VM, Shaohua Y, Huiquin Z. Oxidative stress mediates angiotensin II-dependent stimulation of sympathetic nerve activity. Hypertension. 46: 533-9. PMID 16116043 DOI: 10.1161/01.HYP.0000179088.57586.26 |
0.054 |
|
| 1999 |
Bianchi S, Bigazzi R, Campese VM. Microalbuminuria in essential hypertension: significance, pathophysiology, and therapeutic implications. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 34: 973-95. PMID 10585306 DOI: 10.1016/S0272-6386(99)70002-8 |
0.054 |
|
| 1998 |
Campese VM, Wurgaft A, Safa M, Bianchi S. Dietary salt intake, blood pressure and the kidney in hypertensive patients with non-insulin dependent diabetes mellitus. Journal of Nephrology. 11: 289-95. PMID 10048494 |
0.053 |
|
| 1992 |
Bianchi S, Bigazzi R, Baldari G, Campese VM. Microalbuminuria in patients with essential hypertension: Effects of several antihypertensive drugs The American Journal of Medicine. 93: 525-528. PMID 1442855 DOI: 10.1016/0002-9343(92)90580-5 |
0.053 |
|
| 1993 |
Campese VM, Karubian F, Bigazzi R. Hemodynamic alterations and urinary albumin excretion in patients with essential hypertension American Journal of Kidney Diseases. 21: 15-21. PMID 8494013 |
0.053 |
|
| 2003 |
Campese VM. A new model of neurogenic hypertension caused by renal injury: pathophysiology and therapeutic implications. Clinical and Experimental Nephrology. 7: 167-71. PMID 14586711 DOI: 10.1007/s10157-003-0238-y |
0.053 |
|
| 1989 |
Campese VM. Calcium, Parathyroid Hormone, and Blood Pressure American Journal of Hypertension. 2: 34S-44S. PMID 2645906 DOI: 10.1093/ajh/2.2.34S |
0.053 |
|
| 2003 |
Bianchi S, Bigazzi R, Amoroso A, Campese VM. Silent ischemia is more prevalent among hypertensive patients with microalbuminuria and salt sensitivity. Journal of Human Hypertension. 17: 13-20. PMID 12571612 DOI: 10.1038/sj.jhh.1001498 |
0.052 |
|
| 1994 |
Campese VM. Salt sensitivity in hypertension: Renal and cardiovascular implications Hypertension. 23: 531-550. PMID 8144222 |
0.052 |
|
| 2005 |
Bianchi S, Bigazzi R, Campese VM. Antagonists of aldosterone and proteinuria in patients with CKD: an uncontrolled pilot study. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 46: 45-51. PMID 15983956 DOI: 10.1053/j.ajkd.2005.03.007 |
0.052 |
|
| 2013 |
Koya D, Campese VM. Statin use in patients with diabetes and kidney disease: the Japanese experience. Journal of Atherosclerosis and Thrombosis. 20: 407-24. PMID 23518468 DOI: DN/JST.JSTAGE/jat/16261 |
0.051 |
|
| 1994 |
Liou HH, Chiang SS, Wu SC, Huang TP, Campese VM, Smogorzewski M, Yang WC. Hypokalemic effects of intravenous infusion or nebulization of salbutamol in patients with chronic renal failure: Comparative study American Journal of Kidney Diseases. 23: 266-271. PMID 8311086 |
0.051 |
|
| 2002 |
Ye S, Zhong H, Yanamadala V, Campese VM. Renal injury caused by intrarenal injection of phenol increases afferent and efferent renal sympathetic nerve activity. American Journal of Hypertension. 15: 717-24. PMID 12160195 DOI: 10.1016/S0895-7061(02)02959-X |
0.05 |
|
| 1992 |
Bigazzi R, Bianchi S, Campese VM, Baldari G. Prevalence of microalbuminuria in a large population of patients with mild to moderate essential hypertension Nephron. 61: 94-97. PMID 1528348 |
0.05 |
|
| 1984 |
Levitan D, Massry SG, Romoff M, Campese VM. Plasma catecholamines and autonomic nervous system function in patients with early renal insufficiency and hypertension: Effect of clonidine Nephron. 36: 24-29. PMID 6361595 |
0.049 |
|
| 1991 |
Bianchi S, Bigazzi R, Baldari G, Campese VM. Long-term effects of enalapril and nicardipine on urinary albumin excretion in patients with chronic renal insufficiency: A 1-year follow-up American Journal of Nephrology. 11: 131-137. PMID 1951474 DOI: 10.1159/000168289 |
0.049 |
|
| 2014 |
Campese VM. Pathophysiology of resistant hypertension in chronic kidney disease. Seminars in Nephrology. 34: 571-6. PMID 25416666 DOI: 10.1016/j.semnephrol.2014.08.011 |
0.048 |
|
| 1987 |
Kulick DL, McIntosh N, Campese VM, Hsueh W, Rahimtoola SH, Massry SG, Elkayam U. Central and renal hemodynamic effects and hormonal response to diltiazem in severe congestive heart failure The American Journal of Cardiology. 59: 1138-1143. PMID 3554952 DOI: 10.1016/0002-9149(87)90862-9 |
0.048 |
|
| 1993 |
Gadallah MF, El-Shahawy MA, Campese VM. Unilateral breast enlargement secondary to hemodialysis arteriovenous fistula and subclavian vein occlusion Nephron. 63: 351-353. PMID 8446276 |
0.048 |
|
| 2011 |
Campese VM, Ku E, Bigazzi R, Bianchi S. Do HMG-CoA reductase inhibitors improve kidney function? The saga continues. Journal of Nephrology. 24: 550-3. PMID 21887675 DOI: 10.5301/jn.5000024 |
0.048 |
|
| 1991 |
Bianchi S, Bigazzi R, Baldari G, Campese VM. Microalbuminuria in patients with essential hypertension. Effects of an angiotensin converting enzyme inhibitor and of a calcium channel blocker American Journal of Hypertension. 4: 291-296. PMID 2059393 |
0.047 |
|
| 2006 |
Campese VM, Mitra N, Sandee D. Hypertension in renal parenchymal disease: why is it so resistant to treatment? Kidney International. 69: 967-73. PMID 16528245 DOI: 10.1038/sj.ki.5000177 |
0.046 |
|
| 2008 |
Bigazzi R, Bianchi S, Buoncristiani E, Campese VM. Increased cardiovascular events in hypertensive patients with insulin resistance: a 13-year follow-up. Nutrition, Metabolism, and Cardiovascular Diseases : Nmcd. 18: 314-9. PMID 17368007 DOI: 10.1016/j.numecd.2006.11.001 |
0.046 |
|
| 1997 |
Campese VM, Amar M, Anjali C, Medhat T, Wurgaft A. Effect of L-arginine on systemic and renal haemodynamics in salt-sensitive patients with essential hypertension. Journal of Human Hypertension. 11: 527-32. PMID 9322835 |
0.044 |
|
| 1993 |
Bigazzi R, Bianchi S, Baldari D, Sgherri G, Baldari G, Campese VM. Long-term effects of a converting enzyme inhibitor and a calcium channel blocker on urinary albumin excretion in patients with essential hypertension American Journal of Hypertension. 6: 108-113. PMID 8471229 DOI: 10.1093/ajh/6.2.108 |
0.043 |
|
| 2003 |
Yang LE, Zhong H, Leong PK, Perianayagam A, Campese VM, McDonough AA. Chronic renal injury-induced hypertension alters renal NHE3 distribution and abundance. American Journal of Physiology. Renal Physiology. 284: F1056-65. PMID 12554635 DOI: 10.1152/ajprenal.00317.2002 |
0.043 |
|
| 1994 |
Bianchi S, Bigazzi R, Valtriani C, Chiapponi I, Sgherri G, Baldari G, Natali A, Ferrannini E, Campese VM. Elevated serum insulin levels in patients with essential hypertension and microalbuminuria. Hypertension. 23: 681-7. PMID 8206563 |
0.043 |
|
| 2011 |
Gill IS, Eisenberg MS, Aron M, Berger A, Ukimura O, Patil MB, Campese V, Thangathurai D, Desai MM. "Zero ischemia" partial nephrectomy: novel laparoscopic and robotic technique. European Urology. 59: 128-34. PMID 20971550 DOI: 10.1016/j.eururo.2010.10.002 |
0.042 |
|
| 1985 |
Nadler JL, McKay M, Campese V, Horton R. Prostacyclin modulates the vascular actions of calcium in humans Advances in Prostaglandin, Thromboxane, and Leukotriene Research. 15: 441-443. PMID 2936137 |
0.041 |
|
| 1986 |
Nadler JL, McKay M, Campese V, Vrbanac J, Horton R. Evidence that prostacyclin modulates the vascular actions of calcium in man Journal of Clinical Investigation. 77: 1278-1284. PMID 3514678 |
0.04 |
|
| 1986 |
Solimon M, Massry SG, Campese VM. Renal hemodynamics and pharmacokinetics of bevantolol in patients with impaired renal function The American Journal of Cardiology. 58: E21-E24. PMID 2878596 DOI: 10.1016/0002-9149(86)90593-X |
0.039 |
|
| 2013 |
Ku E, Campese V. Is lipid management effective for all stages of CKD?. Blood Purification. 35: 26-30. PMID 23343543 DOI: 10.1159/000345932 |
0.039 |
|
| 1988 |
Campese VM. Effects of calcium antagonists on deranged modulation of the renal function curve in salt-sensitive patients with essential hypertension The American Journal of Cardiology. 62: 85-91. PMID 3052001 DOI: 10.1016/0002-9149(88)90038-0 |
0.039 |
|
| 1996 |
Bigazzi R, Bianchi S, Baldari G, Campese VM. Clustering of cardiovascular risk factors in salt-sensitive patients with essential hypertension: role of insulin. American Journal of Hypertension. 9: 24-32. PMID 8834703 DOI: 10.1016/0895-7061(95)00268-5 |
0.039 |
|
| 1994 |
Bigazzi R, Bianchi S, Baldari D, Sgherri G, Baldari G, Campese VM. Microalbuminuria in salt-sensitive patients: A marker for renal and cardiovascular risk factors Hypertension. 23: 195-199. PMID 8307628 |
0.038 |
|
| 1997 |
Bianchi S, Bigazzi R, Campese VM. Microalbuminuria in essential hypertension. Journal of Nephrology. 10: 216-9. PMID 9377730 |
0.038 |
|
| 1991 |
Chervu I, Koss M, Campese VM. Bilateral renal cortical necrosis in two patients with neisseria meningitidis sepsis American Journal of Nephrology. 11: 411-415. PMID 1809040 DOI: 10.1159/000168348 |
0.037 |
|
| 1989 |
Jamison M, Widerhorn J, Weber L, Campese V, Vasquez J, Hovanessian L, Rahimtoola SH, Elkayam U. Central and renal hemodynamic effects of a new agonist at peripheral dopamine- and beta-2 adrenoreceptors (dopexamine) in patients with heart failure American Heart Journal. 117: 607-614. PMID 2537556 DOI: 10.1016/0002-8703(89)90735-7 |
0.037 |
|
| 2016 |
Campese VM. Predictors of blood pressure response to spironolactone. Journal of Hypertension. 34: 845-847. PMID 27027381 DOI: 10.1097/HJH.0000000000000897 |
0.036 |
|
| 2004 |
Davidson MB, Bazargan M, Bakris G, Peters Harmel A, Campese V, Basta E. ImmunoDip: an improved screening method for microalbuminuria. American Journal of Nephrology. 24: 284-8. PMID 15087587 DOI: 10.1159/000077854 |
0.036 |
|
| 1989 |
Campese VM. Effect of antihypertensive agents on renal function and on sodium-volume status Advances in Experimental Medicine and Biology. 252: 331-346. PMID 2675558 |
0.035 |
|
| 1986 |
Lempert KD, Kolb JA, Swartz RD, Campese V, Golper TA, Winchester JF, Nolph KD, Husserl FE, Zimmerman SW, Kurtz SB. A multicenter trial to evaluate the use of the CAPD "O" set. Asaio Transactions / American Society For Artificial Internal Organs. 32: 557-9. PMID 3778768 |
0.034 |
|
| 1992 |
Gadallah MF, Ahmad B, Karubian F, Campese VM. Pregnancy in patients on chronic ambulatory peritoneal dialysis American Journal of Kidney Diseases. 20: 407-410. PMID 1415211 |
0.034 |
|
| 2004 |
Nadim MK, Dua R, Campese VM. Antihypertensive drugs and the kidney. Current Cardiology Reports. 6: 403-8. PMID 15485598 |
0.034 |
|
| 1995 |
Liou HH, Huang TP, Campese VM. Effect of long-term therapy with captopril on proteinuria and renal function in patients with non-insulin-dependent diabetes and with non-diabetic renal diseases. Nephron. 69: 41-8. PMID 7891796 |
0.034 |
|
| 2005 |
Sica DA, Giles TD, Black HR, Campese VM. ACE inhibitors: over two decades of use. Journal of Clinical Hypertension (Greenwich, Conn.). 7: 531-7. PMID 16227772 |
0.034 |
|
| 2007 |
Park J, Campese V. Clinical characteristics of resistant hypertension: the importance of compliance and the role of diagnostic evaluation in delineating pathogenesis. Journal of Clinical Hypertension (Greenwich, Conn.). 9: 7-12. PMID 17215649 |
0.033 |
|
| 2010 |
Schneider EL, Campese VM. Adverse drug responses: An increasing threat to the well-being of older patients: Comment on "Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older". Archives of Internal Medicine. 170: 1148-9. PMID 20625023 DOI: 10.1001/archinternmed.2010.186 |
0.032 |
|
| 1991 |
Campese VM, Parise M, Karubian F, Bigazzi R. Abnormal renal hemodynamics in black salt-sensitive patients with hypertension Hypertension. 18: 805-812. PMID 1743761 |
0.032 |
|
| 2006 |
Campese VM, Park J. Use of antagonists of aldosterone in patients with chronic kidney disease: Potential advantages and risks. Journal of Hypertension. 24: 2157-9. PMID 17053534 DOI: 10.1097/01.hjh.0000249690.88865.90 |
0.031 |
|
| 2009 |
Ku E, Park J, Vidhun J, Campese V. The case for dual renin-angiotensin system inhibition - Reply Archives of Internal Medicine. 169: 1931. |
0.03 |
|
| 1999 |
Campese VM, Nosrati S. Diagnosis and evaluation of secondary hypertension. Clinical Cornerstone. 2: 27-39. PMID 10682193 |
0.03 |
|
| 1996 |
Campese VM. The kidney in the hypertensive black. Ethnicity & Health. 1: 145-51. PMID 9395558 DOI: 10.1080/13557858.1996.9961781 |
0.03 |
|
| 2007 |
Campese VM. Diuretics are preferred over angiotensin II-converting enzyme inhibitors for initial therapy of uncomplicated hypertension. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 50: 197-202. PMID 17660021 DOI: 10.1053/j.ajkd.2007.06.005 |
0.029 |
|
| 1984 |
Elkayam U, Weber L, Campese VM, Massry SG, Rahimtoola SH. Renal hemodynamic effects of vasodilation with nifedipine and hydralazine in patients with heart failure Journal of the American College of Cardiology. 4: 1261-1267. PMID 6501724 DOI: 10.1016/S0735-1097(84)80147-3 |
0.029 |
|
| 2011 |
Ku E, Nasreen T, Park J, Campese VM. Metabolic and Dietary Influences on Sympathetic Nervous System Activity Nutritional and Metabolic Bases of Cardiovascular Disease. 298-302. DOI: 10.1002/9781444318456.ch38 |
0.028 |
|
| 1992 |
Alexiewicz JM, Gaciong Z, Parise M, Karubia F, Massry SG, Campese VM. Effect of dietary sodium intake on intracellular calcium in lymphocytes of salt- sensitive hypertensive patients American Journal of Hypertension. 5: 536-541. PMID 1327000 DOI: 10.1093/ajh/5.8.536 |
0.028 |
|
| 1987 |
Campese VM, Iseki K. Contrast-induced acute renal failure Advances in Experimental Medicine and Biology. 212: 135-144. PMID 3303846 |
0.027 |
|
| 1992 |
Chervu I, Karubian F, Campese VM. The role of endothelial factors, cyclosporine, and erythropoietin in hypertension in chronic renal failure Current Opinion in Cardiology. 7: 776-781. |
0.026 |
|
| 2010 |
Cioni A, Sordini C, Cavallini I, Bigazzi R, Campese VM. Angiotensin receptor blocker telmisartan improves insulin sensitivity in peritoneal dialysis patients. Peritoneal Dialysis International : Journal of the International Society For Peritoneal Dialysis. 30: 66-71. PMID 20056982 DOI: 10.3747/pdi.2008.00155 |
0.026 |
|
| 1995 |
Bigazzi R, Bianchi S, Nenci R, Baldari D, Baldari G, Campese VM. Increased thickness of the carotid artery in patients with essential hypertension and microalbuminuria. Journal of Human Hypertension. 9: 827-33. PMID 8576899 |
0.026 |
|
| 2013 |
Campese VM. Interventional hypertension: a new hope or a new hype? The need to redefine resistant hypertension. Journal of Hypertension. 31: 2118-21; discussion . PMID 24077243 DOI: 10.1097/HJH.0b013e328364d3f1 |
0.026 |
|
| 2012 |
Ku E, Ananthapanyasut W, Campese VM. IgA nephropathy in a patient with ulcerative colitis, Graves' disease and positive myeloperoxidase ANCA. Clinical Nephrology. 77: 146-50. PMID 22257545 |
0.025 |
|
| 2012 |
Ku E, Ananthapanyasut W, Campese VM. IgA nephropathy in a patient with ulcerative colitis, Graves disease and positive myeloperoxidase ANCA Clinical Nephrology. 77: 146-150. DOI: 10.5414/CN106770 |
0.025 |
|
| 2010 |
Bianchi S, Bigazzi R, Campese VM. Intensive versus conventional therapy to slow the progression of idiopathic glomerular diseases. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 55: 671-81. PMID 20097461 DOI: 10.1053/j.ajkd.2009.11.006 |
0.025 |
|
| 2015 |
Campese VM, Lakdawala R. THE CHALLENGES OF BLOOD PRESSURE CONTROL IN DIALYSIS PATIENTS. Recent Patents On Cardiovascular Drug Discovery. PMID 26567722 |
0.025 |
|
| 1988 |
Campese VM. Cardiovascular instability during hemodialysis Kidney International. 33: S186-S190. PMID 3283408 |
0.025 |
|
| 1997 |
Bianchi S, Bigazzi R, Campese VM. Altered circadian blood pressure profile and renal damage. Blood Pressure Monitoring. 2: 339-345. PMID 10234137 |
0.024 |
|
| 1999 |
Campese VM. Salt-sensitive hypertension: renal and cardiovascular implications. Nutrition, Metabolism, and Cardiovascular Diseases : Nmcd. 9: 143-56. PMID 10464787 |
0.024 |
|
| 2013 |
Campese VM, Raju S. Altering Serum Lipids to Reduce Progression of Chronic Kidney Disease Nutritional Management of Renal Disease. 241-248. DOI: 10.1016/B978-0-12-391934-2.00016-3 |
0.024 |
|
| 1985 |
Campese VM, Massry SG. Plasma catecholamines and vascular reactivity in acute and chronic renal failure Contributions to Nephrology. 49: 128-133. PMID 3830563 |
0.024 |
|
| 1984 |
Campese V, Easterling RE, Finkelstein F. Renal osteodystrophy and the status of aluminum and other trace metals in CAPD patients: A panel review Peritoneal Dialysis Bulletin. 4: 129-136. |
0.023 |
|
| 1991 |
Gadallah M, Massry SG, Bigazzi R, Horst RL, Eggena P, Campese VM. Intestinal absorption of calcium and calcium metabolism in patients with essential hypertension and normal renal function American Journal of Hypertension. 4: 404-409. PMID 2069773 |
0.023 |
|
| 1996 |
Campese VM, Bianchi S. Is deterioration of renal function in essential hypertension predictable? Contributions to Nephrology. 119: 83-90. PMID 8783596 |
0.023 |
|
| 2006 |
Bigazzi R, Bianchi S, Batini V, Guzzo D, Campese VM. Metabolic risk factors and markers of cardiovascular and renal damage in overweight subjects. American Journal of Hypertension. 19: 426-31. PMID 16580581 DOI: 10.1016/j.amjhyper.2005.10.002 |
0.023 |
|
| 2010 |
Campese V, Schneider EL. Reevaluating the use of antihypertensive medications, a first step toward reducing polypharmacy in very old patients. Journal of Clinical Hypertension (Greenwich, Conn.). 12: 621-4. PMID 20695939 DOI: 10.1111/j.1751-7176.2010.00304.x |
0.021 |
|
| 1991 |
Campese VM, Bigazzi R. The role of hypertension in the progression of renal diseases American Journal of Kidney Diseases. 17: 43-47. PMID 2024672 |
0.021 |
|
| 1997 |
Toto RD, Kirk KA, Coresh J, Jones C, Appel L, Wright J, Campese V, Olutade B, Agodoa L. Evaluation of serum creatinine for estimating glomerular filtration rate in African Americans with hypertensive nephrosclerosis: results from the African-American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Journal of the American Society of Nephrology : Jasn. 8: 279-87. PMID 9048347 |
0.021 |
|
| 1994 |
Campese VM. Is hypertension in chronic renal failure neurogenic in nature? Nephrology Dialysis Transplantation. 9: 741-742. |
0.02 |
|
| 2001 |
Campese VM, Lasseter KC, Ferrario CM, Smith WB, Ruddy MC, Grim CE, Smith RD, Vargas R, Habashy MF, Vesterqvist O, Delaney CL, Liao WC. Omapatrilat versus lisinopril: efficacy and neurohormonal profile in salt-sensitive hypertensive patients. Hypertension. 38: 1342-8. PMID 11751715 |
0.018 |
|
| 1996 |
Campese VM. Neurogenic factors in hypertensive patients with chronic renal failure and on dialysis Seminars in Dialysis. 9: 390-391. |
0.018 |
|
| 2009 |
Ku E, Park J, Vidhun J, Campese V. The hazards of dual renin-angiotensin blockade in chronic kidney disease. Archives of Internal Medicine. 169: 1015-8. PMID 19506167 DOI: 10.1001/archinternmed.2009.128 |
0.018 |
|
| 2007 |
Campese VM, Bedwani DN, Park J. Hypertension, SNS overactivity, and the kidney: Adverse consequences and therapeutic outlook Dialogues in Cardiovascular Medicine. 12: 199-205. |
0.018 |
|
| 1985 |
Campese VM, Feinstein EI, Gura V, Mason WD, Massry SG. Pharmacokinetics of atenolol in patients treated with chronic hemodialysis or peritoneal dialysis Journal of Clinical Pharmacology. 25: 393-395. PMID 4031118 |
0.018 |
|
| 1988 |
Campese VM. Orthostatic hypotension: Idiopathic and uremic Kidney International. 34: S-152-S-155. PMID 3054232 |
0.017 |
|
| 2006 |
Dua R, Nadim MK, Soung J, Campese VM. Renal ischemia: How commonly does it cause renal failure? Current Hypertension Reviews. 2: 255-261. DOI: 10.2174/157340206778742584 |
0.016 |
|
| 1984 |
Campese VM, Iseki K, Massry SG. Plasma catecholamines and vascular reactivity in uremic and dialysis patients Contributions to Nephrology. 41: 90-98. PMID 6525874 |
0.016 |
|
| 1996 |
el-Shahawy MA, Mesa C, Koss M, Campese VM. A 19-year-old female with fever, acroparesthesia, and progressive deterioration of renal function. American Journal of Nephrology. 16: 417-24. PMID 8886180 DOI: 10.1159/000169035 |
0.016 |
|
| 2000 |
Campese VM, Bianchi S, Bigazzi R. Is microalbuminuria a predictor of cardiovascular and renal disease in patients with essential hypertension? Current Opinion in Nephrology and Hypertension. 9: 143-7. PMID 10757219 DOI: 10.1097/00041552-200003000-00008 |
0.014 |
|
| 1997 |
Bianchi S, Bigazzi R, Nenci R, Campese VM. Hyperinsulinemia, circadian variation of blood pressure and end-organ damage in hypertension. Journal of Nephrology. 10: 325-33. PMID 9442446 |
0.014 |
|
| 1991 |
Campese VM, Karubian F. Renal consequences of salt and hypertension Seminars in Nephrology. 11: 549-560. PMID 1745882 |
0.014 |
|
| 1994 |
Bigazzi R, Baldari G, Sgherri G, Campese VM. Diurnal variations of blood pressure and microalbuminuria in essential hypertension American Journal of Hypertension. 7: 23-29. PMID 8136107 |
0.013 |
|
| 1989 |
Campese VM. Sodium and calcium metabolism in the pathophysiology of essential hypertension Nefrologia. 9: 347-352. |
0.013 |
|
| 1990 |
Campese VM. Autonomic nervous system dysfunction in uraemia Nephrology Dialysis Transplantation. 5: 98-101. PMID 2129472 |
0.013 |
|
| 2007 |
Campese VM, Park J. HMG-CoA reductase inhibitors and renal function. Clinical Journal of the American Society of Nephrology : Cjasn. 2: 1100-3. PMID 17942762 DOI: 10.2215/CJN.04060907 |
0.012 |
|
| 1997 |
Campese VM, Scarpelli P. Introduction Journal of Nephrology. 10: 171. DOI: 10.1159/000166693 |
0.012 |
|
| 1989 |
Campese VM, Liu C. Antihypertensive therapy and progression of renal failure Contributions to Nephrology. 75: 155-166. PMID 2697500 |
0.011 |
|
| 1997 |
Campese VM. Why is salt-sensitive hypertension so common in blacks? Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 12: 399-403. PMID 9075116 DOI: 10.1093/ndt/12.3.399 |
0.01 |
|
| 2016 |
Campese VM. The MesoAmerican nephropathy: a regional epidemic of chronic kidney disease? Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. PMID 26801771 DOI: 10.1093/ndt/gfv430 |
0.01 |
|
| 2015 |
Campese VM. Statins and the kidney: friend or foe? The Lancet. Diabetes & Endocrinology. 3: 161-2. PMID 25660357 DOI: 10.1016/S2213-8587(14)70260-8 |
0.01 |
|
| 2014 |
Campese VM. Left ventricular function and chronic kidney disease: how soon does it start? Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 29: 1989-91. PMID 25209365 DOI: 10.1093/ndt/gfu223 |
0.01 |
|
| 2014 |
Campese VM. Reply to 'resistant hypertension and central aortic pressure'. Journal of Hypertension. 32: 699. PMID 24477099 DOI: 10.1097/HJH.0000000000000089 |
0.01 |
|
| 2012 |
Park J, Campese VM. Resistant hypertension and obstructive sleep apnea in end-stage renal disease. Journal of Hypertension. 30: 880-1. PMID 22495130 DOI: 10.1097/HJH.0b013e328352f4c5 |
0.01 |
|
| 2011 |
Gill IS, Eisenberg MS, Aron M, Berger A, Ukimura O, Patil MB, Campese V, Thangathurai D, Desai MM. Re: "zero Ischemia" partial nephrectomy: Novel laparoscopic and robotic technique Journal of Urology. 186: 1803-1804. DOI: 10.1016/j.juro.2011.08.006 |
0.01 |
|
| 2010 |
Campese VM. Oxidative stress and sympathetic activity in hypertension. American Journal of Hypertension. 23: 456. PMID 20404802 DOI: 10.1038/ajh.2010.19 |
0.01 |
|
| 2009 |
Ku E, Campese VM. Aldosterone and hypertension in African Americans. American Journal of Hypertension. 22: 1234. PMID 19924116 DOI: 10.1038/ajh.2009.174 |
0.01 |
|
| 2008 |
Mailloux LU, Campese VM. Hypertension in chronic dialysis patients Handbook of Dialysis Therapy. 857-886. DOI: 10.1016/B978-1-4160-4197-9.50070-3 |
0.01 |
|
| 2005 |
Campese VM, Nadim MK. Natriuretic Peptides Hypertension. 169-192. DOI: 10.1016/B978-0-7216-0258-5.50108-3 |
0.01 |
|
| 1998 |
Campese VM, Scarpelli PT. Journal of Nephrology: Introduction Journal of Nephrology. 11: 277. |
0.01 |
|
| 1997 |
Campese VM, Bianchi S, Bigazzi R. Hypertension, hyperlipidemia and microalbuminuria. Contributions to Nephrology. 120: 11-21. PMID 9257043 |
0.01 |
|
| 1994 |
Garber AJ, Campese VM, Franz MJ, Hoogwerf B, Levy J, Mitch W, Moore MA, Steffes MW, Bertani T, Meyer T, Parving HH, Mogensen CE, Adler S, Lebovitz H, Walser M, et al. Consensus development conference on the diagnosis and management of nephropathy in patients with diabetes mellitus Diabetes Care. 17: 1357-1361. PMID 7821182 |
0.01 |
|
| 1993 |
Campese VM. Reply to mann American Journal of Hypertension. 6: 95. DOI: 10.1093/ajh/6.1.95 |
0.01 |
|
| 1993 |
Brenner BM, Campese VM, Maschio G, Oldrizzi L, Rugiu C. The Fourth Verona Seminar on Nephrology: Foreword American Journal of Kidney Diseases. 21: 1. |
0.01 |
|
| 1990 |
Campese VM, Liu CL. Sexual dysfunction in uremia. Endocrine and neurological alterations Contributions to Nephrology. 77: 1-14. PMID 2188780 |
0.01 |
|
| 1989 |
Campese V. Identifying and treating hypertension in the black and Hispanic population Nephrology News & Issues. 3: 19. PMID 2594105 |
0.01 |
|
| 1989 |
Campese VM, Maiorano G, Mancia G, Salvetti A. Advances in Pathophysiology and Management of Hypertension American Journal of Hypertension. 2: 1S-1S. DOI: 10.1093/ajh/2.2.1S |
0.01 |
|
| 1987 |
Campese VM. Management of essential hypertension. Whom, when and how to treat Contributions to Nephrology. 54: 38-53. PMID 3552436 |
0.01 |
|
| 1986 |
Campese VM. Calcium, parathyroid hormone, and sympathoadrenal system American Journal of Nephrology. 6: 29-32. PMID 3548361 |
0.01 |
|
| 1986 |
Massry SG, Iseki K, Campese VM. Serum calcium, parathyroid hormone, and blood pressure1 American Journal of Nephrology. 6: 19-28. PMID 3548360 DOI: 10.1159/000167211 |
0.01 |
|
| 1985 |
Campese VM. Adrenergic nervous system in hypertension Contributions to Nephrology. 49: 145-155. PMID 3007023 |
0.01 |
|
| 1984 |
Bream R, Campese V, Massry SG, Rahimtoola SH, Chandraratna PAN. Subdiaphragmatic fluid mimicking loculated pericardial effusion on echocardiography The American Journal of Cardiology. 54: 1388-1389. PMID 6507324 DOI: 10.1016/S0002-9149(84)80114-9 |
0.01 |
|
| 1984 |
Campese VM, Saglikes Y, Iseki K, Massry SG. The relationship between body phosphate and blood pressure Advances in Experimental Medicine and Biology. 178: 271-274. PMID 6391098 |
0.01 |
|
| 1984 |
Glassock RJ, Feinstein EI, Campese VM, Finck E, Silberman H, Chandrasoma P. Hypertension in a renal transplant recipient1,2 American Journal of Nephrology. 4: 262-271. PMID 6383044 |
0.01 |
|
| 1983 |
Campese VM. Quiz of month: question 2 American Journal of Nephrology. 3: 285, 295. PMID 6638087 |
0.01 |
|
| 1983 |
Campese VM. Sympatho-adrenal system and the kidney in hypertension American Journal of Nephrology. 3: 128-138. PMID 6346873 DOI: 10.1159/000166702 |
0.01 |
|
| Hide low-probability matches. |